Sandler Laura Lee — SEC Form 4 filings
SEC reporting owner CIK 2075401. 10 Form 4 filings on record with FilingPulse; latest filed 2026-09-15.
Transaction summary — filings shown
Covers all 10 filings on record, filed 2025-07-01 to 2026-09-15. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 19 legs across 8 filings — 35,106 shares, $1,942,488 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 13.
- Largest priced transaction: sale of 4,000 shares @ $92.01 ($368,054) in Oruka Therapeutics, Inc., filed 2026-09-01.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Oruka Therapeutics, Inc. (ORKA) | Chief Operating Officer | 10 | — | 19 legs · 35,106 sh · $1,942,488 | 13 |
Form 4 filings — Sandler Laura Lee
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-09-15 | 4 | Oruka Therapeutics, Inc. (ORKA) | Sale (S): 906 @ $95.71 | EDGAR |
| 2026-09-01 | 4 | Oruka Therapeutics, Inc. (ORKA) | Option exercise (M): 5,000 @ $7.80 · Sale (S): 1,000 @ $91.05 · Sale (S): 4,000 @ $92.01 · Option exercise (M): 5,000 (derivative) @ $0 | EDGAR |
| 2026-07-01 | 4 | Oruka Therapeutics, Inc. (ORKA) | Option exercise (M): 5,000 @ $7.80 · Sale (S): 2,237 @ $93.85 · Sale (S): 2,263 @ $94.75 · Sale (S): 500 @ $95.47 · Option exercise (M): 5,000 (derivative) @ $0 | EDGAR |
| 2026-06-15 | 4 | Oruka Therapeutics, Inc. (ORKA) | Sale (S): 600 @ $69.69 | EDGAR |
| 2026-05-01 | 4 | Oruka Therapeutics, Inc. (ORKA) | Option exercise (M): 5,000 @ $7.80 · Sale (S): 2,200 @ $62.58 · Sale (S): 1,800 @ $64.15 · Sale (S): 300 @ $65.10 · Sale (S): 400 @ $66.06 · Sale (S): 200 @ $67.16 · +2 more | EDGAR |
| 2026-03-17 | 4 | Oruka Therapeutics, Inc. (ORKA) | Sale (S): 600 @ $41.30 | EDGAR |
| 2026-03-02 | 4 | Oruka Therapeutics, Inc. (ORKA) | Option exercise (M): 5,000 @ $7.80 · Sale (S): 2,325 @ $33.28 · Sale (S): 2,675 @ $33.81 · Option exercise (M): 5,000 (derivative) @ $0 | EDGAR |
| 2026-01-23 | 4 | Oruka Therapeutics, Inc. (ORKA) | Grant/award (A): 32,500 @ $0 · Grant/award (A): 130,000 (derivative) @ $0 | EDGAR |
| 2026-01-02 | 4 | Oruka Therapeutics, Inc. (ORKA) | Option exercise (M): 5,000 @ $7.80 · Sale (S): 8,748 @ $28.17 · Sale (S): 3,144 @ $29.08 · Sale (S): 1,108 @ $29.75 · Option exercise (M): 5,000 (derivative) @ $0 | EDGAR |
| 2025-07-01 | 4 | Oruka Therapeutics, Inc. (ORKA) | Grant/award (A): 25,000 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=2075401 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →